# Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)

> **NCT00796419** · PHASE3 · TERMINATED · sponsor: **Emory University** · enrollment: 31 (actual)

## Conditions studied

- Lung Injury, Acute (ALI)
- Respiratory Distress Syndrome, Acute (ARDS)

## Interventions

- **DRUG:** 5% human albumin
- **DRUG:** 6% hetastarch

## Key facts

- **NCT ID:** NCT00796419
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2015-11
- **Final completion:** 2016-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796419, "Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00796419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*